R 753
Pill imprint R 753 has been identified as Glyburide and metformin hydrochloride 5 mg / 500 mg.
Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy.
Glyburide/metformin 5 mg / 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Glyburide and metformin hydrochloride Images
- Imprint:
-
R 753
- Strength:
- 5 mg / 500 mg
- Color:
- Blue
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium hydroxide
sorbic acid
titanium dioxide
triacetin
FD&C Blue No. 2
FD&C Yellow No. 6
methacrylic acid - methyl methacrylate copolymer (1:2)
ferrosoferric oxide
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Actavis
- National Drug Code (NDC):
- 00228-2753
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0138 | Amerisource Health Services |
| 67544-0511 | Prepak Systems Inc (repackager) |
Note: Inactive ingredients may vary.
More Glyburide and Metformin Hydrochloride resources
- Glyburide/Metformin (Wolters Kluwer)
- glyburide and metformin (Cerner Multum)
- glyburide and metformin (Micromedex) - Includes Dosage Information
- Glyburide and Metformin (FDA)
- Glyburide/Metformin Hydrochloride (Wolters Kluwer)


